{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:45:36Z","timestamp":1792215936886,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clbc.2026.08.017","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:44:51Z","timestamp":1787438691000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Megha","family":"Schmalzle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Radigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4294-9693","authenticated-orcid":false,"given":"Deep","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridevi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meytal","family":"Fabrikant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clbc.2026.08.017_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.017_bib0002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2017.19130","article-title":"Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012","volume":"319","author":"Plevritis","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.clbc.2026.08.017_bib0003","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.clbc.2026.08.017_bib0004","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMoa2302344","article-title":"Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer","volume":"389","author":"Whelan","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.clbc.2026.08.017_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer \u2014 primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clbc.2026.08.017_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.clbc.2026.08.017_bib0007","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1200\/JCO.2002.11.101","article-title":"Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less","volume":"20","author":"Fisher","year":"2002","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2026.08.017_bib0008","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.ejca.2013.02.031","article-title":"Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial","volume":"49","author":"Blamey","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.017_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2009.10.007","article-title":"Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2\u00d72 randomised clinical trial in patients with low risk of recurrence","volume":"46","author":"Winzer","year":"2010","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2026.08.017_bib0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.clbc.2026.08.017_bib0011","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.2017.023788","article-title":"Implementation of surgeon-initiated gene expression profile testing (Oncotype DX) among patients with early-stage breast cancer to reduce delays in chemotherapy initiation","volume":"13","author":"Losk","year":"2017","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.017_bib0012","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/modpathol.2013.36","article-title":"Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis","volume":"26","author":"Klein","year":"2013","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.clbc.2026.08.017_bib0013","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/cncr.33422","article-title":"Breast conservation among older patients with early-stage breast cancer: locoregional recurrence following adjuvant radiation or hormonal therapy","volume":"127","author":"Tringale","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.017_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1470-2045(24)00661-2","article-title":"Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial","volume":"26","author":"Meattini","year":"2025","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.017_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jnci\/djz068","article-title":"Expected monetary impact of oncotype DX score-concordant systemic breast cancer therapy based on the TAILORx trial","volume":"112","author":"Mariotto","year":"2020","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.017_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000534096","article-title":"Budget impact of the Oncotype DX breast recurrence score\u00ae Test in patients with early primary hormone-receptor-positive, HER2-negative, node-positive breast cancer in Germany","volume":"19","author":"Lux","year":"2024","journal-title":"Breast Care"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.017_bib0017","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","article-title":"Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)","volume":"74","author":"Smith","year":"2009","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.017_bib0018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.23.02270","article-title":"Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA","volume":"42","author":"Jagsi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.017_bib0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/jnci\/djae262","article-title":"Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis","volume":"117","author":"Karlsson","year":"2025","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"16","key":"10.1016\/j.clbc.2026.08.017_bib0020","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1001\/jama.2012.13444","article-title":"Empirical evaluation of very large treatment effects of medical interventions","volume":"308","author":"Pereira","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2026.08.017_bib0021","doi-asserted-by":"crossref","unstructured":"Radigan R., Fu S.L., Barney A., et al. Ultrahypofractionated partial breast irradiation following oncoplastic surgery: secondary analysis of a phase II trial. Radiat Oncol. 2025;20(1). Available from https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02630-x. Accessed July 8, 2025.","DOI":"10.1186\/s13014-025-02630-x"},{"issue":"13","key":"10.1016\/j.clbc.2026.08.017_bib0022","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1200\/JCO.22.02171","article-title":"Endocrine treatment for 5 years or radiation for 5 days for patients with early breast cancer older than 65 years: can we do it right?","volume":"41","author":"Naoum","year":"2023","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.clbc.2026.08.017_bib0023","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1056\/NEJMra1307118","article-title":"Systemic therapy for estrogen receptor\u2013positive, HER2-negative breast cancer","volume":"383","author":"Burstein","year":"2020","journal-title":"N Engl J Med"},{"issue":"10502","key":"10.1016\/j.clbc.2026.08.017_bib0024","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(25)00832-3","article-title":"Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial","volume":"406","author":"Brain","year":"2025","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.clbc.2026.08.017_bib0025","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/jamaoncol.2017.1261","article-title":"Use of molecular tools to identify patients with indolent breast cancers with ultralow risk over 2 decades","volume":"3","author":"Esserman","year":"2017","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2026.08.017_bib0026","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.21.02019","article-title":"Outcome of patients with an ultralow-risk 70-gene signature in the MINDACT trial","volume":"40","author":"Lopes Cardozo","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:31:14Z","timestamp":1792215074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1526820926001503"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.017","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Omission of Oncotype Dx Genomic Testing in Ultra-Low-Risk Luminal A Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}